Toggle Location Modal

Non Hodgkin's Lymphoma: Symptoms, Causes, Treatment

Medically Reviewed by
Dr. Aman Priya Khanna
Non Hodgkin's Lymphoma

Hexa Health Benefits

Trusted Doctors and Top Hospitals

Consultations with expert surgeons

Extensive assistance throughout your treatment

WhatsApp Expert
Non Hodgkin's Lymphoma
Medically Reviewed by Dr. Aman Priya Khanna Written by Rajath R Prabhu

Book Consultation

Non-Hodgkin’s lymphoma is a group of cancers that mess with an individual’s immune system. From youngsters to adults, no one is immune to this disease. But there’s good news! Cutting-edge research and treatment advances offer better outcomes for those fighting non-Hodgkin’s lymphoma.

There are several non-Hodgkin’s lymphoma symptoms that can accompany the disease. But here’s the thing: every case is unique, with different subtypes and characteristics. That is why personalised treatment plans are crucial, targeting the specific type and stage of the disease. 

So what are the treatment options? And what are its stages and types? Continue reading to find out. 

Disease Name

Non-Hodgkin Lymphoma

Symptoms

 

Swollen lymph nodes in your neck, armpits or groyne.

Causes

Mutation, Gender, Chemical exposure

Diagnosis

Physical examination, Blood tests, Imaging tests, Biopsy

Treated by

Medical and Surgical Oncologist

Treatment Options

Watchful waiting, Chemotherapy, Radiation therapy, Hormonal therapy, Targeted therapy

What is Non-Hodgkin’s Lymphoma?

Non-Hodgkin’s lymphoma (NHL) is a cancer affecting the lymphatic system, a crucial part of the immune system. It occurs when the body’s lymphocytes, a type of white blood cell, start to grow abnormally and uncontrollably. Lymphocytes may develop in just one place or many sites in the body. Non-Hodgkin’s lymphoma is different from Hodgkin’s lymphoma. 

The incidence rates for non-Hodgkin’s lymphoma for men and women in India are 4.0/100,000 and 2.8/100,000,2 respectively. Non-Hodgkin's lymphoma is more common than the other type of lymphoma, Hodgkin’s lymphoma. The primary differentiating characteristic of Hodgkin’s lymphoma vs non-Hodgkin’s lymphoma is the presence of Reed-Sternberg cells in Hodgkin’s lymphoma.

Types of Non-Hodgkin’s Lymphoma

Non-Hodgkin’s lymphoma comprises a diverse group of lymphoid cancers, each with its own unique characteristics. There are over 60 subtypes of non-Hodgkin lymphomas. They can either be indolent (slow-growing) or aggressive (fast-growing). The most common non-Hodgkin’s lymphoma types include:

Aggressive B-cell Non-Hodgkin’s Lymphomas

  1. Diffuse Large B-cell Lymphoma (DLBCL): This is the most common type of NHL, accounting for 25%-30% of all cases. It is characterised by fast-growing, large B-cells. It can occur in lymph nodes or outside of the lymphatic system.

  2. Mantle Cell Lymphoma: This type of NHL is characterised by the involvement of small B-cells in the lymph nodes’ mantle zone (outer ring of the small lymphocytes). Mantle cell lymphoma accounts for about 5% of all NHL cases. It tends to be aggressive and commonly affects older adults.

  3. Burkitt Lymphoma: It is one of the fastest-growing forms of NHL, often occurring in children and young adults. However, it also has high rates of remission and cure. This type of cancer comprises approximately 1% to 5% of all NHL cases. 

Aggressive T-cell Non-Hodgkin’s Lymphomas

  1. Peripheral T-Cell Lymphoma: It is characterised by the development of a group of T-cells and natural killer lymphomas in lymphoid tissues. This form of cancer accounts for about 6% of all non-Hodgkin lymphomas.

  2. Anaplastic Large Cell Lymphoma: It is a rare type of lymphoma that typically affects lymph nodes and organs. This cancer has two subtypes: one affecting children and young adults and the other affecting older adults. 

Indolent B-cell Lymphomas

  1. Follicular Lymphoma: This is the second most common type of NHL that accounts for about 30% of all cases. Follicular lymphoma is a slow-growing cancer in the lymph nodes, bone marrow and other organs. 

  2. Marginal Zone Lymphoma: It arises in the marginal zone, an area between the lymphoid follicles and the surrounding tissue. There are three primary types of marginal zone lymphoma (nodal marginal zone lymphoma, splenic marginal zone lymphoma, and extranodal marginal zone lymphoma). It comprises 7% of all NHL cases. 

Indolent T-cell Lymphomas

  1. Cutaneous T-Cell Lymphoma: It primarily affects the skin. This type of lymphoma involves abnormal T-cells accumulating in the skin, leading to skin lesions, itching, and rash. Common subtypes of cutaneous T-cell lymphoma include Mycosis fungoides and Sezary syndrome. 

Stages of Non-Hodgkin’s Lymphoma 4

Source: https://www.lls.org/lymphoma/non-hodgkin-lymphoma/diagnosis/nhl-staging

The staging of non-Hodgkin’s lymphoma is typically done using the Ann Arbor staging system, which helps determine the spread of the disease. The stages are described by Roman numerals I-IV. Additionally, an “E” designation may be added to indicate the involvement of extranodal sites. Non-Hodgkin’s lymphoma stages are as follows:

Stage I: The disease in this stage can include either of the following:

  1. The cancer is confined to a single lymph node or organ, like tonsils (I).

  2. Lymphoma is found in a single group of lymph nodes outside the lymph system (IE).

Stage II: This stage can be categorised by either of the following:

  1. Individuals have cancer in two or more lymph node groups on the same side of the diaphragm (either above or below) (II).

  2. The cancerous cells are present in a group of lymph nodes or a single area of the nearby organ (IIE). 

Stage III: Either of the following describes this stage:

  1. The presence of cancer in lymph node groups above and below the diaphragm. 

  2. Lymphoma is found in lymph nodes above the diaphragm and the spleen. 

Stage IV: There is an extensive spread of cancer. It involves one or more organs outside the lymphatic system, like the bone marrow, liver, or lungs.

Symptoms of Non-Hodgkin’s Lymphoma 

Source: https://filinf.it/en/about-limphomas/non-hodgkin-lymphomas-nhl/

Non-Hodgkin lymphoma can present with various symptoms, although some individuals may experience no symptoms at all. However, one must remember that having these symptoms does not necessarily mean they have NHL. These symptoms are common to several conditions. Common non-Hodgkin’s lymphoma symptoms may include:

  1. Swollen Lymph Nodes: Painless swelling of the lymph nodes, typically in the neck, armpits, or groyne, is a common symptom of NHL.

  2. Abdominal Pain or Swelling: NHL can affect organs in the abdominal area, leading to discomfort, pain, or swelling. However, abdominal pain is not always a sign of serious illness. 

  3. Chest Pain, Coughing, or Difficulty Breathing: NHL involvement in the lung tissues or lymph nodes inside the chest can cause chest pain, coughing, or trouble breathing. 

  4. Fatigue: Persistent and unexplained fatigue or weakness that does not improve with rest can be a symptom of NHL.

  5. Skin Rash or Itching: Some subtypes of NHL, such as cutaneous T-cell lymphoma, may cause skin-related symptoms, including rashes, itching, and skin lesions.

  6. A Feeling of Fullness: Individuals may experience a feeling of bloating or fullness after eating just a little. This may happen due to an enlarged spleen.  

B Symptoms

Non-Hodgkin’s lymphoma may also cause certain B symptoms. These symptoms help with the prognosis and staging of the disease. B symptoms include:

  1. Unexplained Fever: A body temperature above 103℉ that lasts two or more hours after home treatment or longer than two days may indicate a serious problem. 

  2. Drenching Night Sweats: It is characterised by profuse sweating that drenches the sheets during the night.

  3. Weight Loss: This includes losing 10% or more of body weight over six months without an apparent cause.

Causes of Non-Hodgkin’s Lymphoma

The exact non-Hodgkin’s lymphoma causes are not known. It develops when the body produces too many lymphocytes. Lymphocytes normally follow a predictable life cycle. The old lymphocytes die to make space for the new ones. However, in Non-Hodgkin’s lymphoma, lymphocytes do not die, and the body keeps producing new ones. This accumulation of lymphocytes in the lymph nodes causes them to swell. 

Non-Hodgkin’s lymphoma often begins in one of the following lymphocytes:

  1. B cells (fights infection)

  2. T cells (kills foreign invaders)

  3. Natural killer cells (kills infected or cancerous cells)

NHL may develop due to chromosomal translocation or mutation/deletion.

Risk Factors of Non-Hodgkin’s Lymphoma

Several risk factors can cause an increased chance of developing non-Hodgkin’s lymphoma. However, most cases of non-Hodgkin’s lymphoma occur in individuals with no identifiable risk factors. These factors include:

  1. Age: NHL can occur at any age. However, it is more common in older adults, with the risk increasing in people aged 60 or above. This is possibly due to accumulated genetic mutations and age-related changes in the immune system. 

  2. Gender: Generally, the risk of NHL is higher in men than women. However, some types of non-Hodgkin’s lymphoma are more common in women. The reason for the same is unknown. 

  3. Family History: Having a parent or sibling with NHL can increase individuals’ risk of developing this disease. Some people may inherit DNA mutations from a parent, increasing their risk of NHL.  

  4. Weakened Immune System: Individuals who have had an organ transplant and take drugs to control their immune system may have a higher risk of NHL. A weakened immune system can fail to control and eliminate abnormal lymphocytes properly. This contributes to the development of the NHL.

  5. Viral and Bacterial Infections: Various infectious agents have been linked to different types of NHL. Some viruses may directly affect the DNA of lymphocytes, transforming them into cancer cells. Others may trigger chronic immune responses and genetic changes in lymphocytes, increasing the risk of NHL. These infections include:

    1. Epstein-Barr Virus (EBV): It is one of the most common infections that spreads through bodily fluids. It increases the risk of certain types of NHL, such as Burkitt lymphoma. 

    2. Human T-Cell Leukaemia Virus Type 1 (HTLV-1): It is an infection that affects the T-cells and causes adult T-cell lymphoma. 

    3. Human Herpes Virus 8 (HHV-8): The infection is associated with primary effusion lymphoma (a rare type of lymphoma) and Kaposi sarcoma (cancer that develops in the lining of lymph and blood vessels). 

    4. Hepatitis C Virus (HCV): A bloodborne infection that may increase the risk of splenic marginal zone lymphoma and diffuse large B-cell lymphoma.

    5. Helicobacter Pylori: This infection is linked to an increased risk of mucosa-associated lymphoid tissue (MALT). 

  6. Chemical Exposure: Prolonged exposure to certain chemicals, such as pesticides, herbicides, solvents, and wood preservatives, may increase the risk of NHL.   

  7. Radiation Exposure: Exposure to radiation has been associated with an increased risk of NHL. This may result from atomic bombs, nuclear reactor accidents, and radiation therapy for other cancers.

  8. Autoimmune Diseases: Some diseases can cause immune system dysfunction, leading to genetic mutations and an increased risk of NHL. These diseases include rheumatoid arthritis, Sjögren syndrome, systemic lupus erythematosus, celiac disease, etc.

Expert Doctors (10)

Dr. Suparno Chakrabarti
Hexa Partner
Hexa Partner

Bone Marrow Transplant, Haemato Oncology, Onc...

35+ Years

Experience

98%

Recommended

Dr. Chezhian Subash
Hexa Partner
Hexa Partner

Clinicial Haematology

28+ Years

Experience

97%

Recommended

NABH Accredited Hospitals (10)

Parakh Hospital, Ghatkopar, Mumbai
JCI
NABH

Parakh Hospital, Ghatkopar, Mumbai

4.8/5(88 Ratings)
Ghatkopar East, Mumbai
Ayushman Hospital And Health Service
JCI
NABH

Ayushman Hospital And Health Service

4.9/5(77 Ratings)
Sector 10, Dwarka, Delhi

Prevention of Non-Hodgkin’s Lymphoma

While there is no guaranteed way to prevent non-Hodgkin’s lymphoma, some strategies may help reduce the risk. These strategies include:

  1. Preventing Infections: Minimising exposure to certain viral and bacterial infections, like HIV, EBV, and HCV, can help reduce the risk of NHL. One should avoid known risk factors for these infections, like unprotected sex and intravenous drug use. 

  2. Maintaining a Healthy Weight: Being overweight or obese can trigger hormonal changes, promoting abnormal cell growth. Therefore, individuals must maintain a healthy weight. 

  3. Adopting a Healthy Lifestyle: People must follow a healthy lifestyle to reduce the risk of NHL. It includes regular physical activity, a balanced diet, and avoiding tobacco and excessive alcohol consumption. These lifestyle changes can support immune function and reduce chronic inflammation. This reduces the risk of NHL. 

  4. Ensuring Occupational Safety: Chemical exposure can increase the risk of NHL. Therefore, employees who work around hazardous chemicals should ensure proper safety measures and protective equipment to reduce exposure.

  5. Getting Regular Health Checkups: Regular medical checkups can help detect early signs of NHL or other health issues. This may help ensure timely intervention if needed.

Diagnosis of Non-Hodgkin’s Lymphoma


Source: https://www.tallahasseecancer.com/services/bone-marrow-aspiration-and-biopsy

Non-Hodgkin’s lymphoma diagnosis typically involves a series of steps to confirm the presence of the disease and determine its type and stage. The diagnostic process begins with a medical history and physical examination of swollen lymph nodes and other abnormalities. Diagnostic tests for NHL may include:

  1. Blood Tests: These tests may be done to assess blood cell counts, liver and kidney function. It also helps detect certain markers that may indicate NHL. 

    1. Complete Blood Count (CBC): Measures and counts the blood cells, such as red blood cells, white blood cells, and platelets

    2. Blood Chemistry Study: Measures the substances that the organs and tissues release in the bloodstream

    3. Lactate Dehydrogenase (LDH) Levels: The test measures LDH levels (an enzyme found in almost all body tissues). High levels may indicate lymphoma. 

  2. Imaging Tests: These are used to visualise lymph nodes and other organs to identify any abnormalities. Imaging tests for NHL include:

    1. Computed Tomography (CT) Scan: It uses X-rays to create detailed cross-sectional body images.

    2. Positron Emission Tomography (PET) Scan: This test uses a radioactive tracer to visualise areas with active cancer cells. 

    3. Magnetic Resonance Imaging (MRI): During this test, radio waves and a powerful magnet is used to produce detailed pictures of organs and tissues.

    4. Ultrasound: The test uses sound waves to create images of internal organs and tissues. 

  3. Biopsy: A tissue biopsy is essential for a definitive NHL diagnosis. A biopsy may include:

    1. Lymph Node Biopsy: The provider removes all or part of the lymph nodes to examine the sample under a microscope for Reed-Sternberg cells.

    2. Bone Marrow Aspiration and Biopsy: If NHL is suspected, a bone marrow biopsy or aspiration may be performed to determine if the lymphoma has spread to the bone marrow. It involves removing a sample of bone marrow from the hipbone. This location provides easy access to bone marrow cells and minimises discomfort for the patient during the procedure.

  4. Hepatitis B and Hepatitis C Test: The test involves checking a blood sample to measure the amounts of hepatitis B and hepatitis C-virus-specific markers. Markers are antigens or antibodies that show if an individual has been exposed to these viruses. 

  5. HIV Test: The doctor may test a blood sample to measure HIV levels and help plan treatment. 

  6. Immunophenotyping: It is a diagnostic test used to analyse the specific proteins or markers expressed on the surface of cells in non-Hodgkin’s lymphoma. This helps identify the type of lymphoma and guide treatment decisions.

How to Prepare for Doctor’s Consultation?

Preparing for a doctor’s consultation for non-Hodgkin’s lymphoma can help patients make the most of their appointment and ensure that all their concerns are addressed. Here are some tips to help them prepare:

  1. Know Pre-Appointment Restrictions: Individuals must make a prior appointment with their provider. They should ask if anything needs to be done in advance, such as diet restriction. 

  2. Note the Symptoms: It is best to list the symptoms experienced, even if they seem unrelated to NHL. 

  3. Gather Key Personal Information: This includes major stresses and recent life changes. 

  4. Enlist Medications: Individuals must list all their current medications, including vitamins, supplements, and herbs. They should also mention the dosages and frequency. This helps the doctor understand possible drug interactions. 

  5. Write Down Questions: List questions and concerns to be discussed with the doctor.  

  6. Bring a Trusted Companion: Having a family member or friend at the appointment can help provide emotional support and remember important details discussed during the consultation.

What to Expect from the Doctor?

During the non-Hodgkin’s lymphoma appointment, the doctor may ask several questions to better understand the patient’s medical history and current health status. Some common questions to expect include:

  1. When did you first experience symptoms?

  2. How severe are your symptoms?

  3. Are the symptoms continuous or occasional?

  4. Does anything improve or worsen these symptoms?

  5. Have you had any previous health issues, medical conditions, or infections?

  6. Do you have a family history of cancer?

  7. Do you smoke or consume alcohol?

  8. Have you been exposed to toxins?

  9. Have you undergone treatments for previous cancers?

Questions to Ask the Doctor

Asking relevant questions during the NHL appointment can help individuals better understand their diagnosis, treatment options, and what to expect. The following are some questions patients may want to ask:

  1. Is non-Hodgkin’s lymphoma causing my symptoms?

  2. What type of NHL do I have?

  3. What stage is my cancer?

  4. Is my NHL aggressive or slow-growing?

  5. Is non-Hodgkin’s lymphoma curable?

  6. What are my treatment options? Which one do you recommend?

  7. What are the side effects of these treatments?

  8. What is the duration of the treatment?

  9. Will the treatment affect my daily life?

  10. What is the expected outcome or prognosis?

  11. Are there any clinical trials available?

  12. What lifestyle changes or supportive care do you recommend?

  13. Should I seek a second opinion? How much will it cost?

Treatment for Non-Hodgkin’s Lymphoma

Non-Hodgkin’s lymphoma treatment depends on several factors, including the type and stage of the disease, the location of the affected lymph nodes or organs, and the individual’s overall health. The main treatment options for NHL include:

  1. Watchful Waiting: If an individual has a slow-growing non-Hodgkin’s lymphoma with no symptoms, treatment may not be needed right away. The doctor may recommend watchful waiting and regular monitoring every few months. This helps them understand if the patient’s cancer is progressing and needs treatment. 

  2. Chemotherapy: This involves powerful drugs to kill or slow the growth of cancer cells. Chemotherapy is often used as the primary treatment for NHL and may be given alone or in combination with other therapies. It may also be a treatment option if lymphoma returns after initial treatment. 

  3. Radiation Therapy: The treatment uses high-energy beams to target and destroy cancer cells. Radiation therapy may be the only required treatment for certain types of slow-growing NHL or those located in just one or two spots. Radiation is usually used after chemotherapy to kill any remaining lymphoma cells. 

  4. Targeted Therapy: It focuses on specific molecules or pathways involved in cancer cell growth. By blocking these pathways, targeted drugs cause cancer cells to die. They are often combined with chemotherapy as an initial treatment or when cancer returns. 

  5. Immunotherapy: This is one of the most promising cancer treatments. Immunotherapy helps the body’s immune system identify and attack cancer cells more effectively. Monoclonal antibodies may be used in NHL treatment.

  6. CAR T-Cell Therapy: This innovative immunotherapy involves modifying a patient’s own T-cells to target and attack cancer cells more effectively. It might be used for some types of B-cell non-Hodgkin’s lymphoma that do not respond to other treatments. 

  7. Bone Marrow Transplant: The doctor may consider a bone marrow transplant to replace damaged bone marrow with healthy stem cells if other treatments haven’t helped. The procedure may be performed after high doses of chemotherapy or radiation to suppress the bone marrow and immune system. 

Procedure Name

Procedure Cost

Chemotherapy

₹ 75,000 to ₹ 2,50,000

Radiation Therapy

₹ 60,000 to ₹ 2,00,000

Targeted Therapy

₹ 80,000 to ₹ 2,25,000

Immunotherapy

₹ 80,000 to ₹ 2,25,000

Bone Marrow Transplant

₹ 15,00,000 to ₹ 27,00,000

Please Note: The selection of the treatment approach is based on the patient’s condition and the treating doctor’s opinion.

Complications of Non-Hodgkin’s Lymphoma

Non-Hodgkin’s lymphoma and its treatment can lead to various complications. Complications may arise depending on several factors. These may include the type and stage of the disease, treatment methods used, and overall health. Complications of the disease are as follows:

  1. Weakened Immune System: The growth of lymphocytes in NHL can take up the space of healthy white blood cells that fight infection. The low level of these cells weakens the immune system. This makes individuals more susceptible to serious infections. 

  2. Febrile Neutropenia: NHL can lead to low levels of neutrophils (white blood cells responsible for fighting infection), increasing the risk of infection. Febrile neutropenia is when a patient develops a fever during significant neutropenia. 

  3. Hyperuricemia and Tumour Lysis Syndrome: Rapid tumour cell breakdown during treatment can lead to tumour lysis syndrome (TLS). This causes the release of uric acid into the bloodstream, leading to hyperuricemia and potential kidney damage. Symptoms of these conditions may include:

    1. Fatigue

    2. Nausea and vomiting

    3. Numbness

    4. Tingling in legs

    5. Joint pain

    6. Decreased urination

  4. Spinal Cord and Brain Compression: The cancerous lymph nodes can grow and spread to surrounding tissues, including the spinal cord and brain. The growth of the lymph nodes near the spinal cord or brain may lead to compression of these organs. 

  5. Hyperleukocytosis: The condition is characterised by a high white blood cell count. It occurs when cancerous lymphocytes multiply rapidly and accumulate in the bloodstream. 

  6. Hypercalcemia: It is a condition in which the calcium level in the blood is above normal. It usually occurs due to adult T-cell lymphoma. This form of cancer releases substances that stimulate bone breakdown, leading to excess calcium in the bloodstream. 

  7. Pericardial Tamponade: Cancerous cells can infiltrate the pericardium (the membrane surrounding the heart), leading to fluid accumulation. Fluid in the pericardial space compresses the heart and impairs its ability to pump effectively. 

  8. Anaemia and Thrombocytopenia: NHL treatment, especially chemotherapy, affects the bone marrow. This may reduce the production of red blood cells and platelets, causing symptoms like:

    1. Fatigue

    2. Weakness

    3. Bleeding

    4. Bruising

  9. Infertility: Chemotherapy and radiation therapy for NHL can affect the patient’s fertility.

  10. Second Cancers: Treatment for NHL can increase the risk of second cancers in future. It happens because these treatments damage some healthy cells along with cancer cells. 

When to See a Doctor?

If an individual experiences any persistent or concerning non-Hodgkin’s lymphoma symptoms, they should visit their doctor. While these symptoms may not always indicate NHL, it is best to get them checked. Symptoms to look out for include:

  1. Swollen glands for more than six weeks

  2. Unexplained fever

  3. Drenching night sweats

  4. Significant weight loss

  5. Unexplained fatigue

Diet for Non-Hodgkin’s Lymphoma


Source: https://addon.life/2020/10/31/diet-non-hodgkin-lymphoma/

While a nutritious diet may not cure non-Hodgkin’s lymphoma, it can support overall health during and after treatment. The following are some dietary tips for individuals with NHL:

  1. Fruits and Vegetables: Fruits and vegetables have fibre, vitamins, and minerals, which are essential for the body. 

    1. Examples of fruits include apples, bananas, berries, etc. 

    2. Some of the vegetables include broccoli, cauliflower, kale, etc. 

  2. Carbohydrates: A diet rich in carbohydrates helps provide energy. Sources of carbohydrates include:

    1. Whole grain bread

    2. Oatmeal

    3. Brown rice

  3. Proteins: A protein-high diet can help the body grow and repair cells and tissues. Sources of proteins include:

    1. Pulses

    2. Eggs

    3. Meat

    4. Fish

  1. Dairy or Dairy Alternatives: Dairy products can help provide calcium, zinc, and protein. Good sources of dairy include:

    1. Milk

    2. Yoghurt

    3. Cheese

  2. Hydration: Drink lots of water and other fluids to stay hydrated, especially if experiencing side effects from treatments.

Foods to Avoid:

People with low levels of white blood cells are more prone to bacterial infections. Therefore, they must avoid certain foods or drinks that contain live bacteria. Examples of these foods include:

  1. Yoghurts, foods, or drinks with live microorganisms that are intended to keep one healthy

  2. Unpasteurised foods and drinks

  3. Raw honey

  4. Certain types of cheese, like blue cheese

Myths vs Facts About Non-Hodgkin’s Lymphoma

Myth: Non-Hodgkin’s lymphoma is contagious. 

Fact: NHL is not contagious. This type of cancer develops due to chromosomal translocations or genetic mutations in the lymphocytes. It cannot be transmitted from one person to another. However, some viruses and infections can increase the risk. 


Myth: Everyone with non-Hodgkin’s lymphoma has the same type of cancer. 

Fact: There are over 60 subtypes of non-Hodgkin’s lymphoma. These subtypes are classified by the type of cells they arise from (B-cells or T-cells), their appearance under the microscope, and the chromosomal features of the cells. Some subtypes are slow-growing (indolent), while others are more aggressive and rapidly progressing.


Myth: Non-Hodgkin’s lymphoma is always fatal. 

Fact: With advances in treatment and early detection, the prognosis for NHL has significantly improved. Most cases of non-Hodgkin’s lymphoma are curable. The disease can also sometimes be cured in its advanced stage. 


Myth: Non-Hodgkin’s lymphoma always needs to be treated immediately. 

Fact: Not true! The urgency of treating NHL varies based on disease characteristics, stage, and symptoms. Immediate treatment may be necessary for aggressive NHL cases. However, watchful waiting is sometimes appropriate for indolent NHL in certain situations.

According to the American Cancer Society, the overall non-Hodgkin’s lymphoma survival rate is 74% for five years. However, it is important to note that survival rates are statistical estimates and may not accurately predict the outcome for an individual patient. They are usually expressed as the percentage of people who survive a certain period (often five years) after the diagnosis. 

Survival Rate for NHL may vary depending on several factors, such as:

  1. The type and stage of the disease

  2. Patient's age

  3. Overall health

The five-year non-Hodgkin’s lymphoma survival rate by age may include:

  1. Between 15 to 39 years: 82.4%

  2. Between 40 to 64 years: 78.5%

  3. Between 65 to 74 years: 72.1%

  4. Ages 75 and older: 55.2%

The five-year survival rate according to the stage of the disease includes:

  1. For stage I, the survival rate of non-Hodgkin’s lymphoma is more than 86%. 

  2. The survival rate for stage II is 78%. 

  3. For stage III, the survival rate is above 72%. 

  4. Stage IV non-Hodgkin’s lymphoma survival rate is almost 64%. 

Prognosis of Non-Hodgkin’s Lymphoma

Non-Hodgkin’s lymphoma prognosis varies depending on several factors. These factors may include:

  1. The type and stage of the disease

  2. The age and overall health of the patient

  3. The treatment response

Generally, the prognosis for NHL can vary due to the many different subtypes.

  1. Some NHL subtypes are more aggressive and have a poorer prognosis, while others are slower-growing and may have a better outlook. 

  2. Many people who get treatment for NHL go into remission, i.e., they do not show signs and symptoms of the condition. 

  3. Some individuals are also considered cured after they have remained in remission for many years.

Takeaway

Non-Hodgkin’s lymphoma is a type of cancer that affects the lymphatic system. Early diagnosis and suitable treatment are critical in managing the disease and improving patient outcomes. With advancements in therapies, many individuals with NHL can achieve remission and enjoy an improved quality of life.

You can consult the experts at HexaHealth if you experience any symptoms of NHL. The HexaHealth team provides comprehensive support and personalised care for individuals diagnosed with NHL. Our team of healthcare professionals offers expert guidance, the latest treatment options, and emotional support throughout the patient’s journey. Get in touch with us TODAY! 

Suggested Reads 

Lymphoma

Chronic Lymphocytic Leukaemia

Acute Lymphocytic Leukaemia

B Cell Lymphoma

FAQs for Non Hodgkin's Lymphoma

Non-Hodgkin’s lymphoma is a group of cancers originating in the lymphatic system. It is characterised by the abnormal growth of lymphocytes, affecting various organs in the body. NHL includes several subtypes with different characteristics.

WhatsApp

Non-Hodgkin’s lymphoma symptoms include:

  1. Painless swelling of lymph nodes

  2. Unexplained fever

  3. Drenching night sweats

  4. Significant weight loss

  5. Fatigue

  6. Abdominal pain or swelling

  7. Chest pain

  8. Coughing

  9. Difficulty breathing

  10. Skin rash or itching

  11. A feeling of fullness

WhatsApp

Reed-Sternberg cells are large, abnormal cells found in Hodgkin’s lymphoma. They have specific characteristics, such as multiple nuclei. Furthermore, their presence or absence is a key diagnostic feature for distinguishing between Hodgkin’s and non-Hodgkin’s lymphoma.

WhatsApp

Early symptoms of Hodgkin’s lymphoma may include:

  1. Painless swelling or enlargement of lymph nodes in the armpits, neck, or groyne

  2. Unexplained fatigue

  3. Unexplained fever and night sweats

  4. Weight loss

  5. Frequent or severe infections

If individuals experience persistent symptoms, they should seek medical evaluation.

WhatsApp

Non-Hodgkin’s lymphoma stages are as follows: 

  1. Stage I: Involves a single lymph node or organ.

  2. Stage II: Cancer spreads to two or more lymph nodes on one side of the diaphragm.

  3. Stage III: Lymphoma is in lymph nodes on both sides of the diaphragm.

  4. Stage IV: Indicates widespread involvement of multiple organs.

WhatsApp

Non-Hodgkin’s lymphoma is a type of cancer originating in the lymphatic system, specifically the lymphocytes. It is characterised by uncontrolled growth and accumulation of abnormal lymphocytes. This forms tumours in lymph nodes or other lymphatic tissues and organs. NHL can be either slow-growing or aggressive. 

WhatsApp

Non-Hodgkin’s lymphoma treatment choice depends on the cancer subtype, stage, and the individual’s overall health. Non-Hodgkin’s lymphoma treatment options include: 

  1. Chemotherapy

  2. Radiation therapy

  3. Targeted therapy

  4. Immunotherapy

  5. Bone marrow transplant

WhatsApp

Non-Hodgkin’s lymphoma encompasses more than 60 types. Each type has distinct characteristics and treatment approaches. Some non-Hodgkin’s lymphoma types include:

  1. Diffuse large B-cell lymphoma

  2. Follicular lymphoma

  3. Mantle cell lymphoma

  4. Marginal zone lymphoma

  5. Burkitt lymphoma

  6. Peripheral T-cell lymphoma

  7. Cutaneous T-cell lymphoma

WhatsApp

B-cell non-Hodgkin’s lymphoma originates from abnormal B-lymphocytes. It is the most common subtype of NHL and includes various subtypes like:

  1. Diffuse large B-cell lymphoma 

  2. Follicular lymphoma

  3. Mantle cell lymphoma

  4. Burkitt lymphoma 

It differs from other subtypes based on its cell of origin and response to specific treatments.

WhatsApp

Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL) are both lymphatic system cancers but differ in cell type and treatment. The differentiating characteristics of Hodgkin’s lymphoma vs non-Hodgkin’s lymphoma include:

  1. HL involves Reed-Sternberg cells, occurs in specific patterns, and has better outcomes. 

  2. NHL involves various lymphocytes, has diverse subtypes, and treatment differs based on subtype and stage.

WhatsApp

The overall five-year non-Hodgkin’s lymphoma survival rate is approximately 74%. However, the survival rate can vary widely based on the following:

  1. NHL subtype

  2. Cancer stage 

  3. Age

  4. The overall health of the patient

WhatsApp

Yes, non-Hodgkin’s lymphoma is often curable. The chances of cure are high when diagnosed early and with certain slow-growing subtypes. Individuals are considered cured when they remain in complete remission for five years.

WhatsApp

The exact non-Hodgkin’s lymphoma causes are not known. However, it develops when the body produces too many lymphocytes. This leads to an accumulation of lymphocytes in the lymph nodes, causing them to swell.

WhatsApp

Some common risk factors for non-Hodgkin’s lymphoma include:

  1. Advanced age (more common in people aged 60 and above)

  2. Weakened immune system (e.g., organ transplantation, HIV/AIDS)

  3. Certain infections (e.g., Epstein-Barr virus, Helicobacter pylori)

  4. Certain chemicals (e.g., pesticides)

  5. Radiation exposure

  6. A family history of NHL

  7. Autoimmune disease (e.g., rheumatoid arthritis, Sjögren syndrome)

WhatsApp

If left untreated, NHL may progress from early to advanced stages. The progression or stages of NHL is as follows:

  1. Stage I: Cancer is limited to a single lymph node or organ.

  2. Stage II: It has spread to two or more lymph nodes on one side of the diaphragm.

  3. Stage III: Involves cancerous lymph nodes on both sides of the diaphragm.

  4. Stage IV: Lymphoma has spread to multiple organs.

WhatsApp

Non-Hodgkin’s lymphoma diagnosis involves a combination of tests, such as:

  1. Physical examination

  2. Blood tests (complete blood count, blood chemistry study)

  3. Imaging tests (CT scan, MRI, PET scan)

  4. Biopsies (lymph node, bone marrow) 

Key indicators include:

  1. Painless swollen lymph nodes

  2. Unexplained fever

  3. Night sweats

  4. Weight loss

  5. Fatigue

WhatsApp

Non-Hodgkin’s lymphoma prognosis varies widely based on factors such as: 

  1. The NHL subtype

  2. Cancer stage

  3. Age

  4. Overall health

  5. Response to treatment

Generally, the NHL has a positive outlook.

WhatsApp

The stage 4 non-Hodgkin’s survival rate is about 64%. However, the rates can vary depending on several factors, including:

  1. NHL subtype

  2. Age

  3. Overall health

  4. Response to treatment

WhatsApp

T-cell non-Hodgkin’s lymphoma originates from abnormal T-lymphocytes. It includes various subtypes like peripheral T-cell lymphoma and cutaneous T-cell lymphoma. 

  1. T-cell NHL is less common than B-cell NHL and differs in cell origin and response to specific treatments. 

  2. It usually has a poorer prognosis than B-cell NHL. 

WhatsApp

Chemotherapy plays a significant role in NHL treatment. It uses powerful drugs to kill or slow the growth of cancer cells. Depending on the NHL subtype and stage, these drugs can be used alone or in combination with other therapies.

WhatsApp

With early diagnosis and advanced treatment, NHL has a high survival rate. Many people with NHL can be cured with no recurrence of the disease. However, some cases of non-Hodgkin’s lymphoma relapse are documented. Relapse can occur several months or years after treatment. However, it is most common within two years of initial treatment.

WhatsApp

Non-Hodgkin’s lymphoma cannot be prevented completely. However, reducing exposure to known risk factors may help lower the risk of developing NHL. These risk factors include:

  1. Infections 

  2. Radiation

  3. Certain chemicals 

Maintaining a healthy lifestyle also helps lower the risk.

WhatsApp

Yes, non-Hodgkin’s lymphoma can return in some individuals, even after successful treatment and remission. Regular follow-up and ongoing monitoring are essential to detect any recurrence early and manage it effectively.

WhatsApp

Untreated non-Hodgkin’s lymphoma can lead to:

  1. Disease progression

  2. Increased symptoms

  3. Complications such as organ involvement or spinal cord compression

Seeking timely medical attention and appropriate treatment is crucial to avoid these risks.

WhatsApp

The treatment of non-Hodgkin’s lymphoma varies depending on the stage of the disease:

  1. Stage I and II: For localised disease, treatment options may include chemotherapy, with or without other treatments.

  2. Stage III and IV: For advanced disease, treatment may involve chemotherapy with immunotherapy, targeted therapy, or radiation therapy. In some cases, stem cell transplant may be considered.

WhatsApp

Non-Hodgkin’s lymphoma can affect people of all ages, genders, and ethnicities. While it is more common in older adults, it can occur in children, young adults, and individuals at any stage of life. NHL is more common in men than women. However, for certain subtypes, women may be at a greater risk. 

WhatsApp

Non-Hodgkin’s lymphoma’s five-year relative survival rate is about 74%. However, survival rates can vary based on several factors. 

WhatsApp

The overall survival rate with non-Hodgkin’s lymphoma can vary based on several factors, including:

  1. The NHL subtype

  2. Stage at diagnosis

  3. Age of the patient

  4. Overall health

  5. Response to treatment

Early detection and appropriate treatment play significant roles in improving survival outcomes.

WhatsApp

The survival rate of non-Hodgkin’s lymphoma varies by age. As per Cancer.Net, the five-year survival rate of different stages is as follows:

  1. Stage I: More than 86% 

  2. Stage II: 78%

  3. Stage III: Above 72%

  4. Stage IV: 64%

WhatsApp

Lymphoma and leukaemia are cancers of the blood and lymphatic system but differ in the primary affected cells. 

  1. Lymphoma originates in lymphocytes (a type of white blood cell) and forms solid tumours in lymph nodes or organs.

  2. Leukaemia affects white blood cells, including lymphocytes, in the bone marrow and bloodstream. This leads to high levels of abnormal cells throughout the body. They generally do not form solid tumours.

WhatsApp

Lymphoma can affect various organs and tissues in the body. The commonly affected area is the lymphatic system, which includes:

  1. Lymph nodes

  2. Spleen

  3. Bone marrow

  4. Thymus

  5. Other lymphatic tissues

In advanced cases, lymphoma can spread to other organs like the liver, lungs, and central nervous system.

WhatsApp

The outlook for individuals with stage 4 non-Hodgkin’s lymphoma can vary depending on the NHL subtype and an individual’s risk factors. The survival for stage 4 is lower than other stages. Though challenging, some individuals may achieve remission with appropriate and aggressive treatment.

WhatsApp

Yes, non-Hodgkin’s lymphoma can spread to other body parts. As a cancer of the lymphatic system, NHL can metastasise to nearby or distant lymph nodes, organs, or tissues. This makes early detection and treatment important.

WhatsApp

Yes, children can have non-Hodgkin lymphoma, although it is relatively rare compared to adults. Childhood NHL includes different subtypes and requires specialised treatment and care for children diagnosed with the disease.

WhatsApp

References

All the articles on HexaHealth are supported by verified medically-recognized sources such as; peer-reviewed academic research papers, research institutions, and medical journals. Our medical reviewers also check references of the articles to prioritize accuracy and relevance. Refer to our detailed editorial policy for more information.


  1. Mayo Clinic. Non-Hodgkin’s lymphoma - Symptoms and causes [Internet]. Mayo Clinic. 2018. link
  2. Non-Hodgkin Lymphoma: Types, Causes, Symptoms & Treatment [Internet]. Cleveland Clinic. 2022. link
  3. The American Cancer Society medical and editorial content team. Non-Hodgkin Lymphoma Stages | Staging Non-Hodgkin Lymphoma [Internet]. www.cancer.org. 2018 [cited 2023 Aug 19]. link
  4. Non-Hodgkin Lymphoma: Types, Causes, Symptoms & Treatment [Internet]. Cleveland Clinic. link
  5. Mayo Clinic. Non-Hodgkin’s lymphoma - Symptoms and causes [Internet]. Mayo Clinic. 2018. link
  6. Sapkota S, Shaikh H. Non-Hodgkin Lymphoma [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2020. link
  7. The American Cancer Society medical and editorial content team. Non-Hodgkin Lymphoma Risk Factors [Internet]. www.cancer.org. 2022. link
  8. The American Cancer Society medical and editorial content team. Can Non-Hodgkin Lymphoma Be Prevented? [Internet]. www.cancer.org. 2020. link
  9. Mayo Clinic. Non-Hodgkin’s lymphoma - Diagnosis and treatment - Mayo Clinic [Internet]. Mayoclinic.org. 2018. link
  10. Katherine Marengo LDN, R.D. Diet and nutrition with non-Hodgkin lymphoma [Internet]. www.medicalnewstoday.com. 2022. link
  11. Christina Chun, MPH. Survival Rates for Non-Hodgkin’s Lymphoma [Internet]. Healthline. 2021. link
  12. Cancer.net. Lymphoma - Non-Hodgkin - Statistics [Internet]. Cancer.net. 2012. link

Last Updated on: 12 July 2024

Disclaimer: The information provided here is for educational and learning purposes only. It doesn't cover every medical condition and might not be relevant to your personal situation. This information isn't medical advice, isn't meant for diagnosing any condition, and shouldn't replace talking to a certified medical or healthcare professional.

Reviewer

Dr. Aman Priya Khanna

Dr. Aman Priya Khanna

MBBS, DNB General Surgery, Fellowship in Minimal Access Surgery, FIAGES

12 Years Experience

Dr Aman Priya Khanna is a well-known General Surgeon, Proctologist and Bariatric Surgeon currently associated with HealthFort Clinic, Health First Multispecialty Clinic in Delhi. He has 12 years of experience in General Surgery and worke...View More

Author

Rajath R Prabhu

Rajath R Prabhu

MSc. Clinical Research I PG Diploma in Public Health Services Management

3 Years Experience

His work in medical content writing and proofreading is noteworthy. He has also contributed immensely to public health research and has authored four scientific manuscripts in international journals. He was assoc...View More

Book Consultation

Latest Health Articles

get the appget the app